Deferred Tax Assets, Valuation Allowance of VACCINEX, INC. from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
VACCINEX, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • VACCINEX, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $115,487,000, a 5.5% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

VACCINEX, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $115,487,000 +$5,971,000 +5.5% 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q4 2023 $109,516,000 +$6,779,000 +6.6% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q4 2022 $102,737,000 +$6,279,000 +6.5% 31 Dec 2022 10-K/A 25 Apr 2024 2023 FY
Q4 2021 $96,458,000 +$7,174,000 +8% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $89,284,000 +$9,775,000 +12% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $79,509,000 +$11,829,000 +17% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $67,680,000 +$10,654,000 +19% 31 Dec 2018 10-K 09 Mar 2020 2019 FY
Q4 2017 $57,026,000 31 Dec 2017 10-K 13 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.